Search papers, labs, and topics across Lattice.
This study introduces an unsupervised anomaly detection framework tailored for quality assurance in multi-center breast MRI datasets, addressing the critical issue of data integrity in medical AI. By creating a benchmark of 17 anomaly types and evaluating four detection methods, the authors reveal that while medium-far and far-out-of-distribution samples can be reliably detected, near-OOD samples present unique challenges that vary by method. The 3D reconstruction-based approach achieves the best balance of performance and generalization, highlighting the necessity of domain-specific adaptations for effective anomaly detection across diverse medical imaging contexts.
Medium-far and far-OOD samples can be detected reliably, but near-OOD anomalies expose critical method-specific vulnerabilities that challenge current practices in medical AI.
Corrupted, inconsistent, or anomalous data silently threatens the safety and reliability of medical AI. Despite growing regulatory recognition of dataset quality assurance (QA) for high-risk medical AI, scalable automated detection remains underdeveloped. We employ unsupervised anomaly detection (AD) and out-of-distribution (OOD) detection as an automated dataset QA mechanism for multi-center dynamic contrast-enhanced breast MRI. We build a controlled AD benchmark of 17 realistic QA-relevant anomaly types from six public datasets (protocol violations, processing errors, incorrect anatomical regions) and propose a taxonomy of radiological image anomalies based on human visual perception, enabling fine-grained analysis of AD failure modes. The benchmark includes near-, medium-far-, far-OOD samples, as well as in-distribution and external normal data. Four methods are evaluated: a projection-based method extended with a domain-specific feature extractor and a novel positional encoding, a reconstruction-based approach extended to full 3D volumes with an augmented training objective, and two unmodified hybrid OOD detection methods. Medium-far- and far-OOD samples are detected reliably, whereas near-OOD samples and external normal data from unseen institutions expose method-specific differences. The 3D reconstruction-based approach best balances detection performance (AUROC: 0.936) and generalization to unseen institutions. The projection-based method with positional encoding achieves the highest overall detection performance (AUROC: 0.954). Both hybrid methods exhibit critical failure modes, confirming that methods validated for one modality or anatomy may not generalize without domain-specific adaptation. Implants and mastectomies remain an open challenge for all methods. Our results establish a foundation and practical guidance on scalable unsupervised QA in medical AI pipelines.